Many trials of hydroxychloroquine for SARS-CoV-2 were redundant and potentially unethical: an analysis of the NIH clinical trials registry

OBJECTIVE: We sought to map the landscape of trials investigating hydroxychloroquine (HCQ) for SARS-CoV-2 in order to draw conclusions about how clinical trials have been conducted in the pandemic environment and offer potential regulatory recommendations. STUDY DESIGN AND SETTING: We identified and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yogendrakumar, Vignan, Dewar, Brian, McGuinty, Michaeline, Dowlatshahi, Dar, Dyason, Claire, Kwok, Edmond SH, Ramsay, Tim, Lund, Hans, Shamy, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590481/
https://www.ncbi.nlm.nih.gov/pubmed/34780978
http://dx.doi.org/10.1016/j.jclinepi.2021.11.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590481/
https://www.ncbi.nlm.nih.gov/pubmed/34780978
http://dx.doi.org/10.1016/j.jclinepi.2021.11.011

Ejemplares similares